AV名湿

Venture Partners at CU Boulder is partnering with BridgeBio to advance novel drug discovery with an underlying genetic basis. Apply by Monday, March 16, 2020.

Vu, an assistant professor in the Department of Computer Science, is improving human cognitive functions using an ear-worn device. To bring the technology to customers worldwide later in 2020, he founded Earable Inc., which now has more than 15 employees.

This year's event 鈥� hosted again by Venture Partners at CU Boulder on Feb. 27 鈥� will feature 18 startups from CU Boulder, CU Anschutz, CU Denver, University of Colorado Colorado Springs, Colorado State University, Colorado School of Mines and NIST.

Randolph, a professor in the Department of Chemical and Biological Engineering, founded VitriVax, a CU Boulder spinout, to commercialize new applications of atomic layer deposition techniques for producing thermally stable vaccines.

Funding will support the ongoing development of a nascent RNA drug screen.

Six Boulder-based startups with ties to CU Boulder were recognized for their innovation with $1.5 million in grants from the Colorado Office of Economic Development and International Trade.

The companies鈥擜rtimus Robotics, Bioloomics, Earable, Emergy, Longpath Technologies, and New Iridium鈥攔epresent several departments across campus.

Inscripta, a digital genome engineering company spun out of CU Boulder research, has just raised another $125 million in a Series D financing on the heels of launching its revolutionary product, The Onyx鈩�.

Led by its current investors Maverick Ventures and Global Frontier Investments, the funding will be used to advance the development of ColdQuanta鈥檚 cold atom Quantum Core technology, the foundation for the company鈥檚 development of quantum computers.

This year's LVC winners included SickStick, Exocure Therapeutics, Programmable Gectosomes, Ultrathin Endoscopes, iFeather, Octave Photonics and Theia.